Advanced Search

 

Study ID Status Title Patient Level Data
105753 Completed Safety & immunogenicity of a booster dose of dTPa vaccine (Boostrix®) co-admnd. with Aventis Pasteur’s meningococcal (serogroups A, C, Y and W-135) polysaccharide vaccine (Menactra™) vs admn. of either vaccine alone in healthy adolescents Study Listed on ClinicalStudyDataRequest.com
105779 Completed A Phase I, open, randomised, controlled study of GSK Biological’s meningococcal serogroup B vaccine versus VA-MENGOC-BC given intramuscularly as a 3-dose primary vaccination with a 6-week interval between the first 2 doses and a third dose at month 6, in healthy young adults.
105874 Completed Bridging Safety & Immunogenicity study of GSK Biologicals' Candidate Malaria Vaccine RTS,S/AS01E (0.5 mL Dose) to RTS,S/AS02D (0.5 mL Dose) Administered IM According to a 0, 1, 2-Month Schedule in Gabonese Children Aged 18 Months to 4 Years Study Listed on ClinicalStudyDataRequest.com
105908 Completed Comparative study evaluating the immunogenicity and safety of MeMuRu-OKA vaccine and measles-mumps-rubella vaccine (Priorix™) co-administered with varicella vaccine (Varilrix™) in children primed with measles-mumps-rubella vaccine Study Listed on ClinicalStudyDataRequest.com
105909 Completed Comparative study evaluating the immunogenicity & safety of MeMuRu-OKA vaccine & measles-mumps-rubella vaccine (Priorix™) co-administered with varicella vaccine (Varilrix™) in children primed with both measles-mumps-rubella & varicella vaccines Study Listed on ClinicalStudyDataRequest.com
105910 Completed Compare immunogenicity & reactogenicity of 2 formulations of GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine (new vs current) given in healthy infants. The DTPa-HBV-IPV vaccine (new formulation) will also be assessed in a 3rd group of subjects Study Listed on ClinicalStudyDataRequest.com
105926 Completed Phase 3, open, age-stratified study to assess immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine administered intramuscularly according to 3-dose schedule (0,1,6 months) in healthy female subjects aged 15 - 55 years and long term follow-up Study Listed on ClinicalStudyDataRequest.com
105987 Completed A single-blind, randomized, controlled, multinational study for the evaluation of safety of GlaxoSmithKline (GSK) Biologicals’ investigational vaccination regimen compared to monovalent Haemophilus influenzae type b (Hib) control vaccine in healthy infants at 2, 4, 6, and 12 to 15 months of age. Study Listed on ClinicalStudyDataRequest.com
106001 Completed A phase III, double-blind, randomized, controlled study to evaluate immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine, administered intramuscularly (0, 1, 6 month schedule) in healthy females aged 18 – 35 years Study Listed on ClinicalStudyDataRequest.com
106006 Completed A Randomised, Single-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Intravenous Infusion of GSK933776 in Patients with Alzheimer's Disease. Study Listed on ClinicalStudyDataRequest.com
106068 Completed A phase I/II, randomized, observer blinded study to evaluate and compare the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ investigational pneumococcal vaccine formulations versus a licensed non-GlaxoSmithKline Biologicals’ vaccine and GlaxoSmithKline Biologicals’ aluminum-based 10-valent pneumococcal conjugate vaccine, in healthy elderly subjects Study Listed on ClinicalStudyDataRequest.com
106069 Completed Study to assess the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV vaccine GSK580299 in healthy female subjects aged 10-25 years Study Listed on ClinicalStudyDataRequest.com
106128 Completed A double-blind, randomised, two-period, crossover drug interaction study to investigate the pharmacokinetic and pharmacodynamic effects of 7 days co-administration of salmeterol (50 mcg bid) with ketoconazole (400 mg od). Study Listed on ClinicalStudyDataRequest.com
106181 Completed An open-label, single-arm study to determine the excretionbalance and metabolic disposition of [14C]GW642444administered as a single dose of an oral solution to healthy malevolunteers Study Listed on ClinicalStudyDataRequest.com
106208 Completed To assess reactogenicity and immunogenicity of GSK Biologicals’ 10-valent pneumococcal conjugate vaccine, when co-administered with GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix™ hexa) at 2, 4 and 6 months of age. Study Listed on ClinicalStudyDataRequest.com
106218 Completed Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride Study Listed on ClinicalStudyDataRequest.com
106252 Completed An open, phase IV study on the immunogenicity and tolerability of Influsplit SSW® 2005/2006 in children aged 6 – 13 years Study Listed on ClinicalStudyDataRequest.com
106260 Completed A Phase IIIb, Randomized, Double-Blind, Placebo-Controlled Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family. Study Listed on ClinicalStudyDataRequest.com
106316 Completed A study to evaluate immunogenicity and safety of Boostrix compared to Adacel when administered as a booster vaccination in adults aged 19 to 64 years of age Study Listed on ClinicalStudyDataRequest.com
106323 Completed A study to evaluate immunogenicity and safety of Boostrix when co-administered with Fluarix in subjects 19 years of age and older Study Listed on ClinicalStudyDataRequest.com
106345 Completed Open, primary vaccination study to assess safety and reactogenicity of GSK Biologicals’ DTPa/Hib vaccine when administered to healthy chinese infants at 3, 4 and 5 months of age. Study Listed on ClinicalStudyDataRequest.com
106367 Completed A partially-blind (observer-blind) study to evaluate the safety and immunogenicity of 3 different vaccination schedules with 2 GSK Biologicals' candidate Plasmodium falciparum vaccines in children aged 5 to 17 months living in Ghana Study Listed on ClinicalStudyDataRequest.com
106369 Completed Safety and immunogenicity study of GSK Biologicals’ investigational vaccination regimen Malaria Vaccine 257049, when incorporated into an Expanded Program on Immunization (EPI) regimen that includes Tritanrix HepB/Hib, OPV, measles and yellow fever vaccination in infants Study Listed on ClinicalStudyDataRequest.com
106372 Completed Observer-blind superior efficacy trial with GlaxoSmithKline Biologicals' influenza vaccine GSK2186877A in elderly subjects Study Listed on ClinicalStudyDataRequest.com
106388 Completed Study to demonstrate non-inferiority of GSK Biologicals’ Hib-MenC given with Infanrix™ penta versus NeisVac-C™ given with Infanrix™ hexa at 3, 5 months of age and persistence prior to a Hib-MenC booster at 11 months and immunogenicity of the booster Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.